Egypt Association for Research in Vision and Ophthalmology (ARVO-EGYPT)
ARVO-Egypt was founded as a group of the National Eye Hospital (Al Watany) in Cairo, Egypt. ARVO-Egypt’s goal is to promote collaboration among ophthalmologists in clinical and epidemiological ophthalmological research. ARVO-Egypt is designated as an Egyptian scientific community by the Egyptian Organizations Ministry and therefore able to approach academic institutions and universities in Egypt about collaborating. ARVO-Egypt became an international chapter affiliate on January 14, 2013.
To promote and develop ophthalmic research in Egypt, with focus on training and advocating systemic methodology in vision research.
- Membership is open to individuals around the globe who are interested in eye and vision research in Egypt and the Persian Gulf. There are no membership dues.
- ARVO-Egypt members use an exclusive ARVO-Egypt ARVOConnect community — an online forum for collaboration: Access here.
Planned 2018 – 2019 activities
- Annual meeting in conjunction with the Al Watany Eye Hospital and Watany Research and Development Center during the Egyptian Ophthalmology Summit: two-days, Sept. 13, 2018.
- Foster communication and exchange of ideas between regional eye researchers.
- Access to online registry forum for regional ophthalmic research projects.
- Travel grant opportunities for young investigators to attend the ARVO Annual Meeting: April 28 – May 2, 2019, Vancouver, British Columbia, Canada.
- ARVO-Egypt President: Abdallah Hassouna, MD
- ARVO-Egypt Secretary: Mohamed El Bahrawy, MD
- ARVO-Egypt Admin/Support: Dina Baddar, MD, MSc
- ARVO-Egypt Contact: Nada Fathy, MD
Samar Moharram, 2018 ARVO-Egypt travel grant recipient
"I am honored to be the winner of the 2018 ARVO-Egypt travel grant, and I am looking forward to attending a fruitful and prestigious ARVO Annual Meeting in Honolulu, Hawaii." -- Samar Sherif Moharram, MD, is a senior resident at Al Watany Eye Hospital with a special interest in glaucoma and pediatric ophthalmology research.